Compositions and methods for treatment of cancer

Details for Australian Patent Application No. 2002341356 (hide)

Owner Yissum Research Development Company Theravir Management L.P.

Inventors Panet, Amos; Irving, Charles; ZakayRones, Zichria

Agent Freehills

Pub. Number AU-B-2002341356

PCT Number PCT/IL02/00765

PCT Pub. Number WO2003/022202

Priority 145397 12.09.01 IL

Filing date 12 September 2002

Wipo publication date 24 March 2003

Acceptance publication date 15 November 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/125 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/08 (2006.01) Viruses, e.g. bacteriophages

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 145397 12.09.01 IL

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002341356

3 March 2005 Assignment before Grant

  Yissum Research Development Company; Ovcure Inc. The application has been assigned to Yissum Research Development Company; Theravir Management L.P.

15 November 2007 Application Accepted

  Published as AU-B-2002341356

3 April 2008 Standard Patent Sealed

8 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

13 May 2010 Section 223 Application Received

  Yissum Research Development Company; Theravir Management L.P. An application to extend the time from 12 Mar 2010 to 12 Apr 2010 in which to pay a renewal fee has been filed . Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Mebourne VIC 3000 2003

1 July 2010 Section 223 Application Allowed

  Yissum Research Development Company; Theravir Management L.P. The time in which to pay a renewal fee has been extended to 12 Apr 2010. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Mebourne VIC 3000 2003

7 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002341357-DYNAMIC WEB ADVERTISEMENT AND CONTENT DISPLAY SYSTEM

2002341355-VACUUM ARC PLASMA GUN DEPOSITION SYSTEM